期刊文献+

艾司西酞普兰治疗老年期抑郁症随机对照研究 被引量:4

Treatment of geriatric depression with escitalopram and fluoxefine
下载PDF
导出
摘要 目的比较艾司西酞普兰和氟西汀治疗老年期抑郁症的疗效和安全性。方法将符合中国精神障碍分类与诊断标准中抑郁症诊断标准的老年患者120例,随机分为艾司西酞普兰组和氟西汀组各60例,观察治疗6周。采用汉密尔顿抑郁量表(HAMD)和临床疗效总评量表(CGI)在治疗前和治疗后第2、4、6周末评估疗效。安全性评估包括不良事件、体检、实验室检查。结果艾司西酞普兰组的有效率和临床治愈率分别为87.3%和64%,氟西汀组分别为82.5%和58.6%,差异无统计学意义(P>0.05)。艾司西酞普兰组和氟西汀组不良反应发生率分别为30.9%和30.6%(P>0.05)。结论艾司西酞普兰治疗老年期抑郁症与氟西汀的疗效相当,耐受性好,起效时间可能早于氟西汀。 Objective To investigate the efficacy and side effect of escitalopram and fluoxetine in treatment of geriatric depression.Methods 120 patients with depression were randomly divided into escitalopram group and fluoxetine group treated with escitalopram and fluoxetine for 6 weeks,respectively.The Hamilton Depression Scale(HAMD)and clinical global impression scale(CGI)were used to assess the therapeutic effect and side effect,respectively.Results The effective rate of escitalopram group and fluoxetine group were 87.3% and 82.5%,respectively.The incidence of side effect of escitalopram group and fluoxetine group were 30.9% and 30.6%,respectively.There was no significant difference between two groups in improvement rate and side effect(P〉0.05).Conclusion Eseitalopram is as effective as Fluoxetine for the treatment of geriatric depression,and has fewer side effect and fast onset than Fluoxetine.
出处 《西部医学》 2011年第11期2107-2108,2111,共3页 Medical Journal of West China
关键词 老年期抑郁症 艾司西酞普兰 氟西汀 Escitalopram Fluoxetine Geriatric depression
  • 相关文献

参考文献4

  • 1StephenM,StabL,于欣,等.精神药理学精要:处方指南[M].济南:山东科学技术出版社,2009:236-243.
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-3)[M].第3版.济南t山东科学技术出版社,2001:83-89.
  • 3司天梅,舒良.关于新抗抑郁药艾司西酞普兰[J].临床精神医学杂志,2007,17(1):68-69. 被引量:124
  • 4Mork A,Kreilgaard D, Sanchez C. The R-enantionmer of citalo- pram counteracts escltalopram-indued increase in entracellular 5- HT-in the frontal cortexof freely moving rats [J]. Neueopharma- cology,2003,45(2): 167-173.

二级参考文献14

  • 1Owens MJ,Knight DL,Nemeroff CB.Second generation SSRIs:human monoamine transporter binding profile of escitalopram and R-fluoxetine[J].Biol Psychiatry,2001,50:345-350.
  • 2Chen FH,Larsen MB,Sanchezc,et al.The S-enantiomer of R,S-citalopram,increases inhibitor binding to the human serotonin transporter by an allosteric mechanism.Comparison with other serotonin transporter inhibitors[J].Eur Neuropsychopharmacology,2005,15:193-198.
  • 3Mork A,Kreilgaard M,Sanchez C.The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats[J].Neuropharmacology,2003,45:167-173.
  • 4Sanchez C.R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalization model[J].Eur J Pharmacol,2003,464:155-158.
  • 5Sanchez C,Gruca P,Papp M.R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model of depression[J].Behav Pharmacol,2003,14:465-470.
  • 6Plenge P,Mellerup ET,Laursen H.Affinity modulation of[^3H]imipramine,[^3H]paroxetine and[^3H]citalopram binding to the 5-HT transporter from brain and platelets[J].Eur J Pharmacol,1991,206:243-250.
  • 7Fava M,Davidson KG.Definition and epidemiology of treatment resistant depression[J].Psychiatr Clin North Am,1996,19:179-200.
  • 8Thase ME.The Concept of Remission:validity and limitations[J].JClin Psychiatry,2006,67:478-481.
  • 9Thase ME.Evaluating antidepressant therapies:Remission as the optimal outcome[J].J Clin Psychiatry,2003,64(Suppl 13):18-25.
  • 10Murdoch D,Keam SJ.Escitalopram:a review of its use in the management of major depressive disorder[J].Drugs,2005,65:2379-2404.

共引文献123

同被引文献44

引证文献4

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部